DISC MEDICINE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.84 USD | +2.68% |
|
+5.99% | -44.88% |
| 05-09 | Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-08 | Stifel Raises Price Target on Disc Medicine to $73 From $71, Keeps Buy Rating | MT |
Chart calendar Disc Medicine, Inc.
b39088c791.KaIJYPqQu5ekJXcIBE12xNyE-NsaW4bsNp4YrRCRnBw.Zsp5JbHPi8XySyFQUxxAnJOpvOhCMM2obuhp8k_JyElYyV1SjcXu35ZqFA~0349cc6b24c2d8bf783fd5041f4d09a2
Upcoming events on Disc Medicine, Inc.
Past events on Disc Medicine, Inc.
| 09/05/2024 13:00 | Q1 2024 Earnings Release |
| 01/04/2024 13:30 | AURORA Phase 2 Study Topline Results Call |
| 21/03/2024 12:00 | Q4 2023 Earnings Release |
| 11/03/2024 14:40 | Leerink Partners Global Biopharma Conference |
| 10/01/2024 22:15 | JPMorgan Healthcare Conference |
| 12/12/2023 02:30 | American Society of Hematology Meeting |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number: 4564 |
| 12/12/2023 01:30 | American Society of Hematology Meeting - Abstract Number: 923 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract Number: 5228 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract Number: 5236 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract Number: 5224 |
| 30/11/2023 19:30 | Piper Sandler Healthcare Conference |
| 16/11/2023 09:30 | Jefferies London Healthcare Conference |
| 15/11/2023 16:30 | Stifel Healthcare Conference |
| 09/11/2023 13:30 | Q3 2023 Earnings Release |
| 27/09/2023 19:25 | Cantor Global Healthcare Conference |
| 13/09/2023 15:30 | H.C. Wainwright Global Investment Conference |
| 13/09/2023 13:50 | Morgan Stanley Global Healthcare Conference |
| 08/09/2023 13:45 | Wells Fargo Healthcare Conference |
| 11/08/2023 13:00 | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -91,0 -80,8 -12.68% | -132 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -47,5 -69,4 31.58% | -91,1 -83,3 -9.46% | -142 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -46,8 -82,4 43.2% | -76,3 -71,8 -6.24% | -119 |
|
Net income Million USD | Released Forecast Spread | -36,0 | -46,8 -78,6 40.39% | -76,4 -71,4 -7.03% | -119 |
|
EPS USD | Released Forecast Spread | -4,49 | -45,1 -4,68 -862.61% | -3,42 -3,23 -5.99% | -4,72 |
| Announcement Date | 02/09/22 | 31/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -15,0 -15,2 1.19% | -25,1 -14,7 -71.45% | -17,3 -19,3 10.06% | -19,0 -19,0 0.29% | -29,7 -20,3 -46.65% | -31,5 -27,0 -16.68% | -31,3 | -31,7 | -34,9 | -37,8 | -35,3 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,2 -14,9 24.42% | -22,8 -14,7 -54.36% | -15,9 -18,8 15.52% | -14,1 -17,8 20.99% | -23,5 -19,1 -23.6% | -26,9 -24,4 -10.23% | -29,5 | -29,9 | -33,1 | -37,8 | -35,3 | |
|
Net income Million USD | Released Forecast Spread | -16,2 | -11,2 -14,1 20.19% | -22,8 -14,1 -61.48% | -15,9 -18,8 15.39% | -14,1 -17,4 18.87% | -23,6 -18,5 -27.17% | -26,9 -25,0 -7.99% | -29,3 | -29,8 | -32,9 | -37,8 | -35,3 |
|
EPS USD | Released Forecast Spread | -1,86 | -40,9 -0,81 -4981.99% | -1,20 -0,75 -60% | -0,74 -0,91 18.83% | -0,58 -0,76 23.83% | -0,97 -0,77 -25.97% | -1,09 -1,04 -5.14% | -1,18 | -1,20 | -1,26 | -1,34 | -1,36 |
| Announcement Date | 23/11/22 | 31/03/23 | 15/05/23 | 11/08/23 | 09/11/23 | 21/03/24 | 09/05/24 | - | - | - | - | - |
| 15/05/2024 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 20/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 21/05/2024 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 21/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Disc Medicine, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IRON Stock
- Calendar Disc Medicine, Inc.
